We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
401
PUT
Crown Castle
CCI
$31.3B
$8K ﹤0.01%
+44,300
New +$7.31M
CSIQ icon
402
Canadian Solar
CSIQ
$1.08B
$8K ﹤0.01%
+227
New +$6.05K
M icon
403
Macy's
M
$6.45B
$8K ﹤0.01%
1,436
-109,664
-99% -$731K
PFE icon
404
PUT
Pfizer
PFE
$152B
$8K ﹤0.01%
15,810
-36,574
-70% -$1.28M
SNAXW
405
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$8K ﹤0.01%
24,000
-8,209
-25% -$3.08K
CUB
406
PUT
DELISTED
Cubic Corporation
CUB
$8K ﹤0.01%
+17,600
New +$828K
AMRN
407
CALL
Amarin Corp
AMRN
$296M
$6K ﹤0.01%
1,350
+225
+20% +$27K
BMRN icon
408
BioMarin Pharmaceuticals
BMRN
$13.5B
$6K ﹤0.01%
+83
New +$8.4K
SWCH
409
PUT
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6K ﹤0.01%
8,500
-41,500
-83% -$707K
DRNA
410
CALL
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6K ﹤0.01%
+15,000
New +$311K
GIX.RT
411
DELISTED
GigCapital2, Inc. Rights, each exchangeable into one-twentieth of a share of Common Stock
GIX.RT
$6K ﹤0.01%
17,400
-42,050
-71% -$13.8K
MNTA
412
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6K ﹤0.01%
+216,400
New +$8.96M
DISH
413
CALL
DELISTED
DISH Network Corp.
DISH
$6K ﹤0.01%
+77,500
New +$2.56M
DBRG icon
414
CALL
DigitalBridge
DBRG
$2.95B
$5K ﹤0.01%
+4,450
New +$43.1K
SNAX
415
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$4K ﹤0.01%
27,331
ESSCR
416
DELISTED
East Stone Acquisition Corporation Right
ESSCR
$4K ﹤0.01%
16,458
-109,663
-87% -$22K
ACIA
417
CALL
DELISTED
Acacia Communications Inc
ACIA
$4K ﹤0.01%
+37,600
New +$2.55M
TCO
418
CALL
DELISTED
Taubman Centers Inc.
TCO
$4K ﹤0.01%
19,000
-52,400
-73% -$1.95M
TGNA
419
CALL
DELISTED
TEGNA Inc
TGNA
$3K ﹤0.01%
+50,000
New +$594K
V icon
420
CALL
Visa
V
$677B
$3K ﹤0.01%
+13,600
New +$2.72M
WFC icon
421
CALL
Wells Fargo
WFC
$264B
$3K ﹤0.01%
+100,000
New +$2.46M
GWPH
422
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3K ﹤0.01%
+7,500
New +$863K
FAST icon
423
PUT
Fastenal
FAST
$60.1B
$2K ﹤0.01%
20,000
IMMR icon
424
CALL
Immersion
IMMR
$248M
$2K ﹤0.01%
+20,000
New +$151K
MDB icon
425
CALL
MongoDB
MDB
$35.3B
$2K ﹤0.01%
+10,300
New +$2.23M

Similar funds

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.